In the last trading session, 0.42 million Compugen Ltd. (NASDAQ:CGEN) shares changed hands as the company’s beta touched 2.67. With the company’s per share price at $0.74 changed hands at -$0.01 or -1.31% during last session, the market valuation stood at $65.02M. CGEN’s last price was a disco
During the last session, Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD)’s traded shares were 2.18 million, with the beta value of the company hitting 1.16. At the end of the trading day, the stock’s price was $0.30, reflecting an intraday loss of -3.29% or -$0.01. The 52-week high for the GLM
Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) has a beta value of 1.96 and has seen 2.23 million shares traded in the recent trading session. The company, currently valued at $48.41M, closed the recent trade at $1.62 per share which meant it lost -$0.26 on the day or -14.06% during that session. The GLM
Vascular Biogenics Ltd. (NASDAQ:VBLT): Can A Stock That's Up 1.852% YTD Still Be Considered In Loss Territory? marketingsentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketingsentinel.com Daily Mail and Mail on Sunday newspapers.
What Will ProQR Therapeutics N.V. (NASDAQ:PRQR) Be Like After It Drops -45.31% From Its Highs? marketingsentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketingsentinel.com Daily Mail and Mail on Sunday newspapers.